Cargando…

SARS-CoV-2 viral dynamics in non-human primates

Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques for which nasopharyngeal and tracheal viral load were frequently assessed. We identified that infected cells had a large b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonçalves, Antonio, Maisonnasse, Pauline, Donati, Flora, Albert, Mélanie, Behillil, Sylvie, Contreras, Vanessa, Naninck, Thibaut, Marlin, Romain, Solas, Caroline, Pizzorno, Andres, Lemaitre, Julien, Kahlaoui, Nidhal, Terrier, Olivier, Ho Tsong Fang, Raphael, Enouf, Vincent, Dereuddre-Bosquet, Nathalie, Brisebarre, Angela, Touret, Franck, Chapon, Catherine, Hoen, Bruno, Lina, Bruno, Rosa Calatrava, Manuel, de Lamballerie, Xavier, Mentré, France, Le Grand, Roger, van der Werf, Sylvie, Guedj, Jérémie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007039/ https://www.ncbi.nlm.nih.gov/pubmed/33730053 http://dx.doi.org/10.1371/journal.pcbi.1008785

Ejemplares similares

Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
por: Marlin, Romain, et al.
Publicado: (2022)

Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates
por: Marc, Aurélien, et al.
Publicado: (2023)

Impact of a PMMA tube on performances of a Vereos PET/CT system adapted for BSL-3 environment according to the NEMA NU2-2012 standard
por: Kahlaoui, Nidhal, et al.
Publicado: (2022)

Computed tomography and [(18)F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates
por: Naninck, Thibaut, et al.
Publicado: (2022)

Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model
por: Hérate, Cécile, et al.
Publicado: (2023)

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
por: Alexandre, Marie, et al.
Publicado: (2022)

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
por: Gonçalves, Antonio, et al.
Publicado: (2020)

Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
por: Marlin, Romain, et al.
Publicado: (2021)

Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020
por: Gámbaro, Fabiana, et al.
Publicado: (2020)

Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques
por: Zabaleta, Nerea, et al.
Publicado: (2022)

Non-human primate models of human respiratory infections
por: Lemaitre, Julien, et al.
Publicado: (2021)

SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota
por: Sokol, Harry, et al.
Publicado: (2021)

Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque
por: Olivo, Anaëlle, et al.
Publicado: (2022)

A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates
por: Woodworth, Joshua S, et al.
Publicado: (2023)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
por: Pizzorno, Andrés, et al.
Publicado: (2019)

RNA-seq accuracy and reproducibility for the mapping and quantification of influenza defective viral genomes
por: Boussier, Jeremy, et al.
Publicado: (2020)

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
por: Madelain, Vincent, et al.
Publicado: (2018)

Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014
por: Casalegno, Jean-Sebastien, et al.
Publicado: (2017)

Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020
por: Boëlle, Pierre-Yves, et al.
Publicado: (2020)

Detection of human bocavirus-1 in both nasal and stool specimens from children under 5 years old with influenza-like illnesses or diarrhea in Gabon
por: Lekana-Douki, Sonia Etenna, et al.
Publicado: (2018)

A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model
por: Fovet, Claire-Maëlle, et al.
Publicado: (2022)

Comparison of Aerosol Deposition Between a Cynomolgus Macaque and a 3D Printed Cast Model of the Animal
por: Creppy, Justina, et al.
Publicado: (2023)

Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2019)

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
por: Maisonnasse, P, et al.
Publicado: (2021)

Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
por: Crescenzo-Chaigne, Bernadette, et al.
Publicado: (2021)

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2021)

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
por: Maisonnasse, Pauline, et al.
Publicado: (2021)

Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2020)

Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
por: Sulbaran, Guidenn, et al.
Publicado: (2022)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2)
por: Weiss, Anne, et al.
Publicado: (2021)

Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus
por: Temmam, Sarah, et al.
Publicado: (2020)

Bidirectional Human–Swine Transmission of Seasonal Influenza A(H1N1)pdm09 Virus in Pig Herd, France, 2018
por: Chastagner, Amélie, et al.
Publicado: (2019)

An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
por: Zabaleta, Nerea, et al.
Publicado: (2021)

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
por: Brouwer, Philip J.M., et al.
Publicado: (2021)

Clinical and virological data of the first cases of COVID-19 in Europe: a case series
por: Lescure, Francois-Xavier, et al.
Publicado: (2020)

Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection
por: Pizzorno, Andrés, et al.
Publicado: (2018)

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Leukocytospermia induces intraepithelial recruitment of dendritic cells and increases SIV replication in colorectal tissue explants
por: Cavarelli, Mariangela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r52mhl29m7574vtjc40ffg25ej